NCT00617851View on ClinicalTrials.gov

Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old

PHASE3CompletedINTERVENTIONAL
Enrollment

1,507

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

June 30, 2008

Conditions
Influenza
Interventions
BIOLOGICAL

Lot A of Influenza virus vaccine

1 injection of the trivalent subunit influenza virus vaccine (lot A) administered intramuscularly

BIOLOGICAL

Lot B of Influenza virus vaccine

1 injection of the trivalent subunit influenza virus vaccine (lot B) administered intramuscularly

BIOLOGICAL

Lot C of Influenza virus vaccine

1 injection of the trivalent subunit influenza virus vaccine (lot C) administered intramuscularly

BIOLOGICAL

Comparator influenza virus vaccine

1 injection of the trivalent subunit influenza virus vaccine administered intramuscularly

BIOLOGICAL

All 3 consecutive lots of influenza virus vaccine pooled

1 injection of the pooled trivalent subunit influenza virus vaccine administered intramuscularly

Trial Locations (2)

Unknown

Centro de Salud Galvan, Santo Domingo

Hosp. Nuestra Sra. Altagracia, Santo Domingo

Sponsors

Lead Sponsor

Novartis Vaccines
All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY

NCT00617851 - Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old | Biotech Hunter | Biotech Hunter